A rising incidence of intermediate- and higher-risk prostate cancer … but what does this mean?

According to another paper to be presented at the Genitourinary Cancers Symposium in Orlando, Florida, that started this morning, there was a 6 percent increase in the proportion of patients being diagnosed with intermediate- or higher-risk prostate cancers between 2011 and 2013. … READ MORE …

From Amsterdam yesterday: European perspectives on the PSA screening issue

A report on the Medscape Oncology web site, published late yesterday, discusses two presentations given yesterday at the European Cancer Conference 2013, currently being held in Amsterdam. … READ MORE …

Hyping the risk for prostate cancer … to what end?

According to a media release issued by Cancer Research UK a few days ago, “Boys born in 2015 will have almost three times the risk of being diagnosed with prostate cancer at some point during their lives than those born in 1990.” … READ MORE …

Estimated prostate cancer cases/deaths in USA in 2013

According to the newly published report, “Cancer statistics, 2013,” now available in the journal CA: A Cancer Journal for Clinicians, prostate cancer will become the most commonly diagnosed cancer of any type in the USA this year. … READ MORE …

Rare variants of adenocarcinoma of the prostate: a 25-year analysis of incidence and mortality

The vast majority of prostate cancers are adenocarcinomas of the prostate, i.e., cancers that start in the epithelial cells of the prostate gland. Most of these adenocarcinomas have a well-defined, “normal” cancer histology. However, there are five categories of rare adenocarcinoma, with differing levels of risk. … READ MORE …

In Denmark … PSA-based testing for risk shows no significant impact on prostate cancer mortality (yet)

The question whether widespread use of the PSA test to test for risk of prostate cancer has a significant impact on prostate cancer-specific mortality continues to be highly controversial and to engender strong emotions among many medical professionals, patients, and prostate cancer advocates. … READ MORE …

Why is likelihood of prostate cancer diagnosis declining?

In an article discussed earlier this week on this web site (click here for more), Howard argued that the USPSTF recommendation to abandon PSA screening in men of ≥ 75 years of age was a key factor in the decrease in the incidence of prostate cancer in men in this age group. But is Dr. Howard right? … READ MORE

What will be the global incidence of prostate cancer by 2030?

According to a new set of projections just published in The Lancet this morning, the total global burden of new cases of cancer will increase by about 75 percent (from 12.7 million in 2008 to 22.2 million in 2030) over the next 30-odd years. … READ MORE …

Reduction of risk for lethal prostate cancer in Sweden

A paper to be presented at the upcoming annual meeting of the American Society for Clinical Oncology (ASCO) suggests that, at least in Sweden, the combination of an increase in PSA testing, early diagnosis, and treatment with curative intent has decreased the risk for and incidence of lethal prostate cancer. … READ MORE …

Incidence and mortality rates for prostate cancer declined again in 2008

The latest actual (as opposed to projected) data on the incidence and mortality rates for prostate cancer specifically (and cancers as a whole) continue to show steady improvements here in the US. … READ MORE …

How many current, PSA-detected, localized prostate cancers are really appropriate for focal therapy?

It is well understood that current Western screening and diagnostic processes commonly identify patients with low volume, low Gleason grade prostate cancer tumors (e.g., a single biopsy core with < 10 percent of the core  positive for cancer of Gleason score 3 + 3 = 6). … READ MORE …

ACS projects > 33,000 prostate cancer deaths in US in 2011

The annual cancer statistics report from the American Cancer Society (Cancer Facts & Figures 2011) has just been released. The report is projecting 240,890 new cases of prostate cancer diagnosis and 33,720 prostate cancer-specific deaths in 2011. These numbers are up, yet again, from the projections for 2010. … READ MORE …

Projected “dramatic” increase in diagnosis of prostate cancer in Canada

A new report has suggested that there will be a 201 percent increase in the annual number of prostate cancer diagnoses in Canada between 2009 and 2021. … READ MORE …

Incidence and mortality rates in 37 European countries

A new analysis by the International Agency for Research on Cancer offers an update on the incidence and mortality rates associated with prostate cancer in Europe over the past 20 years. … READ MORE …

“Selling” the positive message about individual testing

A paper in the July issue of Psychological Science addresses the influence of men’s perceptions on their willingness to be tested for prostate cancer (at least in one part of Germany). … READ MORE …